Amanda MacMillan is a health and science writer and editor. Her work appears across brands like Health, Prevention, SELF, O Magazine, Travel + Leisure, Time Out New York, and National Geographic's The ...
(HealthDay News) — Despite evidence that has suggested metformin might have potential in cancer, a new study finds the medication doesn’t help patients with pancreatic ductal adenocarcinoma (PDAC).
First-in-human study of MM-141: A novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3. Overall survival in intermediate-stage hepatocellular carcinoma (HCC) patients after first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results